Serum MIF levels were found to be significantly higher in patients with UC than in normal controls [6], and another study suggest that immunization with helper T epitope DNA-vaccine targeting MIF may be a useful approach for the treatment of colitis including inflammatory bowel diseases [7]. Here, MIF is linked to inflammatory bowel disease.